Cargando…

Itraconazole Amorphous Solid Dispersion Tablets: Formulation and Compaction Process Optimization Using Quality by Design Principles and Tools

BCS Class II drugs, such as itraconazole (ITZ), exhibit poor solubility (1–4 ng/mL) and so require solubility enhancement. Therefore, ITZ and Kollidon(®) VA64 (KOL) amorphous solid dispersions (ASDs) were produced using hot-melt extrusion (HME) to improve ITZ’s poor solubility. A novel strategy for...

Descripción completa

Detalles Bibliográficos
Autores principales:	Triboandas, Hetvi, Pitt, Kendal, Bezerra, Mariana, Ach-Hubert, Delphine, Schlindwein, Walkiria
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9693276/ https://www.ncbi.nlm.nih.gov/pubmed/36365216 http://dx.doi.org/10.3390/pharmaceutics14112398

Ejemplares similares

Homogenization of Amorphous Solid Dispersions Prepared by Electrospinning in Low-Dose Tablet Formulation
por: Fülöp, Gergő, et al.
Publicado: (2018)

Downstream Processing of Itraconazole:HPMCAS Amorphous Solid Dispersion: From Hot-Melt Extrudate to Tablet Using a Quality by Design Approach
por: Mishra, Saurabh M, et al.
Publicado: (2022)

Polymer–Surfactant System Based Amorphous Solid Dispersion: Precipitation Inhibition and Bioavailability Enhancement of Itraconazole
por: Feng, Disang, et al.
Publicado: (2018)

10122 Development of an In Vitro in Vivo Correlation of Itraconazole Spray-Dried Dispersion Tablets
por: Coutinho, Ana Luisa, et al.
Publicado: (2021)

Amorphous Nanoparticulate Formulation of Sirolimus and Its Tablets
por: Shen, Yudong, et al.
Publicado: (2018)

Formulation Characterization and Pharmacokinetic Evaluation of Amorphous Solid Dispersions of Dasatinib
por: Dharani, Sathish, et al.
Publicado: (2022)

In Vitro-In Silico Tools for Streamlined Development of Acalabrutinib Amorphous Solid Dispersion Tablets
por: Mudie, Deanna M., et al.
Publicado: (2021)

Amorphous Solid Dispersion Tablets Overcome Acalabrutinib pH Effect in Dogs
por: Mudie, Deanna M., et al.
Publicado: (2021)

Development of Robust Tablet Formulations with Enhanced Drug Dissolution Profiles from Centrifugally-Spun Micro-Fibrous Solid Dispersions of Itraconazole, a BCS Class II Drug
por: Marano, Stefania, et al.
Publicado: (2023)

Formulation and evaluation of fast dissolving tablets of haloperidol solid dispersion
por: Eisa, Aya M., et al.
Publicado: (2022)

Development and Validation of an in-line API Quantification Method Using AQbD Principles Based on UV-Vis Spectroscopy to Monitor and Optimise Continuous Hot Melt Extrusion Process
por: Almeida, Juan, et al.
Publicado: (2020)

Orally Disintegrating Tablets Containing Melt Extruded Amorphous Solid Dispersion of Tacrolimus for Dissolution Enhancement
por: Ponnammal, Poovizhi, et al.
Publicado: (2018)

Spray-Dried Paracetamol/Polyvinylpyrrolidone Amorphous Solid Dispersions: Part I—Stability of Powders and Tablets
por: Ritters, Lena, et al.
Publicado: (2021)

Utilizing Drug Amorphous Solid Dispersions for the Preparation of Dronedarone per os Formulations
por: Kapourani, Afroditi, et al.
Publicado: (2023)

Formulation and evaluation of fast dissolving tablet containing domperidone ternary solid dispersion
por: Patel, Dasharath M., et al.
Publicado: (2014)

Superiority of Mesoporous Silica-Based Amorphous Formulations over Spray-Dried Solid Dispersions
por: Zhang, Hongwei, et al.
Publicado: (2022)

Recent Advances in Amorphous Solid Dispersions: Preformulation, Formulation Strategies, Technological Advancements and Characterization
por: Tambe, Srushti, et al.
Publicado: (2022)

Fed- and Fasted-State Performance of Pretomanid Amorphous Solid Dispersions Formulated with an Enteric Polymer
por: Nguyen, Hanh Thuy, et al.
Publicado: (2023)

Formulation and Evaluation of Loperamide HCl Oro Dispersible Tablets
por: Alejandro, Blasco, et al.
Publicado: (2020)

High Acceptability of an Orally Dispersible Tablet Formulation by Children
por: Wagner-Hattler, Leonie, et al.
Publicado: (2021)

Revisiting dispersible milk-drug tablets as a solid lipid formulation in the context of digestion
por: Binte Abu Bakar, Syaza Y., et al.
Publicado: (2019)

Continuous Formulation Approaches of Amorphous Solid Dispersions: Significance of Powder Flow Properties and Feeding Performance
por: Szabó, Edina, et al.
Publicado: (2019)

Aceclofenac fast dispersible tablet formulations: Effect of different concentration levels of Avicel PH102 on the compactional, mechanical and drug release characteristics
por: Yasmin, Riffat, et al.
Publicado: (2020)

Thermal Stability of Amorphous Solid Dispersions
por: Jelić, Dijana
Publicado: (2021)

Repurposing antifungals: population pharmacokinetics of itraconazole and hydroxy-itraconazole following administration of a nanocrystal formulation
por: Jansen, Anouk M E, et al.
Publicado: (2023)

Unravelling the Miscibility of Poly(2-oxazoline)s: A Novel Polymer Class for the Formulation of Amorphous Solid Dispersions
por: Everaerts, Melissa, et al.
Publicado: (2020)

Formulating a heat- and shear-labile drug in an amorphous solid dispersion: Balancing drug degradation and crystallinity
por: Davis, Daniel A., et al.
Publicado: (2021)

A Hot-Melt Extrusion Risk Assessment Classification System for Amorphous Solid Dispersion Formulation Development
por: Kyeremateng, Samuel O., et al.
Publicado: (2022)

A novel architecture for achieving high drug loading in amorphous spray dried dispersion tablets
por: Mudie, Deanna M., et al.
Publicado: (2020)

Characteristics of Skin Deposition of Itraconazole Solubilized in Cream Formulation
por: Kim, Hyeongmin, et al.
Publicado: (2019)

Formulation and evaluation of microsphere based oro dispersible tablets of itopride hcl
por: Shah, Sanjay, et al.
Publicado: (2012)

A tabletability change classification system in supporting the tablet formulation design via the roll compaction and dry granulation process
por: Su, Junhui, et al.
Publicado: (2023)

Itraconazole nanosuspension for oral delivery: Formulation, characterization and in vitro comparison with marketed formulation
por: Nakarani, M., et al.
Publicado: (2010)

Co-Amorphous Solid Dispersions for Solubility and Absorption Improvement of Drugs: Composition, Preparation, Characterization and Formulations for Oral Delivery
por: Karagianni, Anna, et al.
Publicado: (2018)

In-Line UV-Vis Spectroscopy as a Fast-Working Process Analytical Technology (PAT) during Early Phase Product Development Using Hot Melt Extrusion (HME)
por: Schlindwein, Walkiria, et al.
Publicado: (2018)

Compaction Behavior of Co-Amorphous Systems
por: Sørensen, Cecilie-Mathilde, et al.
Publicado: (2023)

Oral Delivery of Niclosamide as an Amorphous Solid Dispersion That Generates Amorphous Nanoparticles during Dissolution
por: Jara, Miguel O., et al.
Publicado: (2022)

Cellulose based polymers in development of amorphous solid dispersions
por: Chavan, Rahul B, et al.
Publicado: (2019)

Preparation and Characterization of Amorphous Solid Dispersions for the Solubilization of Fenretinide
por: Zuccari, Guendalina, et al.
Publicado: (2023)

Amorphous Solid Dispersion as Drug Delivery Vehicles in Cancer
por: Budiman, Arif, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_cf378snssat79ngae9aus2je39